Skip to main content

Table 3 Number of relapses in each study group during the 12-month study period

From: A non-randomized clinical trial to evaluate the effect of fingolimod on expanded disability status scale score and number of relapses in relapsing-remitting multiple sclerosis patients

Number of relapses Study groups
Treatment group
Number (%)
Control group
Number (%)
0 25 (100) 0 (0)
1 0 (0) 11 (36.7)
2 0 (0) 19 (63.3)